Nonselective Beta-Blockers May Reduce Prostate Cancer Recurrence Risk
The perioperative period is receiving increased attention as a platform to inhibit cancer progression, according to investigators.
Medications
SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
Gene Polymorphism Might Influence Cinacalcet Response
A recent findings, if validated, may partly explain inter-individual differences in the response to cinacalcet treatment for secondary hyperparathyroidism.
High-Dose IV Iron Reduces Myocardial Infarction in Hemodialysis
Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis.
Mixing Patiromer With Juices Does Not Impair Potassium-Binding Capacity
The FDA already approved apple or cranberry juice as alternatives for suspension.
Steroid Reduces the Risk for Major Adverse Kidney Events in IgA Nephropathy
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
Outpatient Gabapentin Rarely Used for Approved Indications
Concomitant use of central nervous system-depressant drugs listed for 58.4% of off-label gabapentin visits
Sodium Polystyrene Sulfonate Ups Risk for Fatal Gastrointestinal Injury in HD
New data from DOPPS support previous studies finding higher risk for gastrointestinal injury after use of sodium polystyrene sulfonate.
Promising Developments That May Improve Lupus Nephritis Management
Recent approval of new drugs for lupus nephritis and promising therapies on the horizon bode well for the care of patients with the kidney disorder.
Emergency Department Visits for Medication Harms Are Frequent
However, most common product type and intent of use associated with these visits vary by age
